Eager to discover the secrets of life itself? The Max Planck Institute for Molecular Genetics stands before us. It is a beacon of scientific discovery in the heart of Berlin.
The Max Planck Institute for Molecular Genetics is part of the Max Planck Society. This society is a leading European research organization. It empowers researchers to innovate and collaborate.
But how did this center for groundbreaking research come to be? The Max Planck Society is the successor to the Kaiser Wilhelm Society. It was founded in Berlin in 1911. The Kaiser Wilhelm Institute for Anthropology, Human Heredity and Eugenics was established in 1927. After the war, some departments moved to the newly founded Max Planck Society. In 1953, it was renamed the MPI for Comparative Hereditary Biology and Hereditary Pathology.
A conscious decision was made to break with the past. In the 1960s, the Max Planck Institute for Molecular Genetics was founded in 1964. This happened with the appointment of Heinz-Günther Wittmann and Heinz Schuster as directors. Thomas Trautner followed in 1965. The then-President of the MPG, Adolf Butenandt, called it a “new foundation”.
Early research focused on DNA replication and gene regulation. Studies were done in bacteria, bacterial phage, and fungi. The structure, function, and evolution of ribosomes were also researched. In 1971, the departments moved to a new building on Ihnestraße.
After the death of H.-G. Wittmann and the retirement of H. Schuster, changes occurred. Hans Lehrach and Hans-Hilger Ropers were appointed. This brought a shift in the scientific orientation of the Institute. Later, Martin Vingron was appointed. Stefan Mundlos was jointly appointed. Bernhard Herrmann was appointed in 2003.
Since 2017, under the direction of Alexander Meissner, the MPIMG has adjusted its scientific focus. The institute fosters a collaborative culture. They embrace curiosity-driven discovery. They are expanding their research faculty. They are building bridges across the scientific environment in Berlin and beyond.
Research at the Max Planck Institute for Molecular Genetics focuses on genome analysis. This includes humans and other organisms. The goal is to understand biological processes and human diseases. The combined efforts of all groups aim to gain new insights into disease development on a molecular level. This contributes to the development of cause-related new medical treatments.
Genome research has transformed molecular genetics. The Max Planck Institute for Molecular Genetics reflects this. The Dept. of Vertebrate Genomics generates tools and information. They help understand the function of most or all genes. The Human Molecular Genetics Dept. searches for disease genes. The Dept. of Computational Molecular Biology exploits data. This allows for a better understanding of biological and disease processes. The Dept. of Developmental Genetics uses functional analysis. This is for understanding developmental mechanisms.
Here, at the Max Planck Institute for Molecular Genetics, scientists decode the very essence of life. They seek to understand the blueprint within us all. Their discoveries offer hope for new medical treatments. The work here truly embodies the spirit of scientific advancement.